Le Young GORTEC, branche du GORTEC est à destination des personnels de santé de moins de 40 ans, impliqués en cancérologie ORL, quelle que soit la spécialité ( oncologue radiothérapeute, oncologue médical, chirurgien ORL ou maxillo-facial, anatomopathologistes, chirurgien dentaire, pharmacien, biologiste). Ses trois missions portent sur l'Enseignement, la Recherche et les Soins de Support en Cancérologie ORL, avec pour chacune un pôle spécifiquement dédié.
Plusieurs actions sont organisées lors des réunions du GORTEC et de l'Intergroupe ORL ainsi qu'avec des partenaires scientifiques et industriels.
L'adhésion à la mailing est gratuite.
Pour toute question ou renseignement ou si vous êtes intéressés pour participer : young.gortec[@]gortec.fr.
Le pôle Enseignement a pour mission de favoriser la diffusion des connaissances et de renforcer la formation scientifique dans le domaine de l’oncologie ORL.
Ses actions comportent notamment :
Le pôle Recherche vise à promouvoir et structurer l’activité scientifique dans l’oncologie ORL. Il s’articule autour de quatre axes principaux :
Le pôle Soins de Support et relations avec les associations de patients se concentre sur une prise en charge globale des patients atteints de pathologies néoplasiques ORL.
Ses actions comprennent notamment :
Une partie des bibliographies sont consultables ici : Veille bibliographique
Linkedin : Young GORTEC
Audrey Larnaudie - Caen ( présidente), Yasmine El Houat - Roanne ( vice-présidente), Florence Huguet - Paris ( coordination avec le GORTEC)
Alizée Simon ( responsable Oncologie Médicale) - Lille, Alice Blache - Lyon ( responsable Oncologie Radiothérapie) , Alexandre Tendron - Rouen ( responsable Chirurgie)
Roman Vion - Rouen (responsable recherche prospective), Rafik Nebbache - Paris ( responsable recherche prospective), Thibault Gauduchon - Lyon ( responsable recherche ancillaire), Pierre-Marie Morice - Orléans ( responsable recherche translationnelle)
Léa Loriguet - Villejuif ( Liaison associations de patients), Hanene Oueslati - Saint Quentin ( Liaison associations de patients) , Mathias Perazzi - Rennes ( Liaison associations de patients)
Dear colleagues, dear friends,
Clinical research is becoming increasingly complex with more constraints for investigators, stricter regulations, and exponentially growing costs for sponsors. In this context, it is essential to preserve and strengthen our academic research potential, particularly through cooperative oncology groups. In the face of this growing complexity, GORTEC is organizing itself by optimizing its partnership research and its internal processes. A key element for the group's sustainability is our ability to create new collaboration opportunities with industrial partners and to diversify our portfolio, which we are actively doing, among other things, by relying on the newly created Early Assets Board. The second ongoing project is to optimize the implementation of each study, ensuring a perfect match between needs and resources, reducing costs, and especially simplifying everything that can be simplified in the protocol, CRF, monitoring, etc. Supported by our strong and motivated operational team, all of this is currently being implemented through a pilot experience conducted for the upcoming study involving patients in the first-line relapse/metastatic setting (Tatiana study).
Driven by the strong involvement of our investigators and the efficiency of our operational team, GORTEC is more determined than ever to meet the growing challenges posed by clinical research!
Dear colleagues, dear friends,
This brand-new issue of the journal revisits the main discussions from last December’s meetings in Charenton, once again chosen as the venue, as it was last year.
You were very many in attendance, and these days provided an opportunity to announce our record number of members.
These meetings allowed us to review completed clinical trials, some of which have now been published, reflecting GORTEC’s national and international standing.
We also exchanged views on future prospects and upcoming trials.
In addition, we were able to confirm the strong momentum of Young GORTEC.
The evening at the Musée Grévin was a wonderful moment of shared experience, highlighted by a memorable visit to the wax figures.
Let us continue our collective efforts to remind everyone that at GORTEC, “We never give up!”
I look forward to seeing you again at the next meetings in June 2026 in Toulouse.
Yours GORTEC-ly